BioSpace News Archive

Press Releases

Cognition Therapeutics Supports Lewy Body Dementia Awareness Month and the Need for Improved Treatments for the Second Most Common Dementia

October 2, 2024
·
7 min read
Press Releases

Intellia Therapeutics to Present New Clinical Data from the Phase 1 Study of nexiguran ziclumeran (nex-z) for the Treatment of Transthyretin (ATTR) Amyloidosis at the 2024 AHA Scientific Sessions

October 2, 2024
·
6 min read
Press Releases

Tagworks Pharmaceuticals Appoints Ken Mills as Chief Executive Officer

October 2, 2024
·
4 min read
Press Releases

Altimmune to Participate in the H.C. Wainwright 8th Annual MASH Virtual Conference

October 2, 2024
·
1 min read
Press Releases

CORRECTING and REPLACING Access Vascular Highlights New Midline Catheter Data at AVA 2024

Data Presented at the AVA Annual Scientific Meeting Shows Significantly Lower Complication and Failure Rates with Access Vascular’s HydroMID® Midline Catheter

October 2, 2024
·
2 min read
Press Releases

DIOSynVax Appoints Ron Moss, MD, as CEO

October 2, 2024
·
3 min read
Press Releases

Eliem Therapeutics Announces Rebranding and Corporate Name Change to Climb Bio, Inc.

October 2, 2024
·
5 min read
Press Releases

Kazia Therapeutics Announces Presentation of Promising Phase I Data Evaluating Concurrent Paxalisib and Radiation Therapy in Patients with Solid Tumor Brain Metastases or Leptomeningeal Metastases Harboring PI3K Pathway Mutations at the American Society for Radiation Oncology 66th Annual Meeting

October 2, 2024
·
6 min read
Press Releases

Immix Biopharma Advances CAR-T NXC-201 to Expansion Cohort Dose Level in U.S. AL Amyloidosis Trial NEXICART-2

October 2, 2024
·
7 min read
Press Releases

Adolore BioTherapeutics to Present at 18th Annual Pain Therapeutics Summit

October 2, 2024
·
3 min read